Global Cushing Syndrome Market 2025-2029

Publisher TechNavio

Published Mar 01, 2025

Length 194 Pages

SKU # INF19750121

Description

Cushing Syndrome Market 2025-2029

The cushing syndrome market is forecasted to grow by USD 2005.6 million during 2024-2029, accelerating at a CAGR of 23.3% during the forecast period. The report on the cushing syndrome market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, rising drug development for cushing syndrome treatment, and favorable reimbursement scenario of cushing syndrome treatment.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's cushing syndrome market is segmented as below:

By Distribution Channel

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Type

Glucocorticoid receptor antagonists
Pituitary directed drugs
Steroidogenesis inhibitors

By Customer Type

Adults
Pediatrics

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rise in incidence of cushing syndrome as one of the prime reasons driving the cushing syndrome market growth during the next few years. Also, increasing growth potential in emerging economies and use of biosimilars for cushing syndrome treatment will lead to sizable demand in the market.

The report on the cushing syndrome market covers the following areas:

Cushing Syndrome Market sizing
Cushing Syndrome Market forecast
Cushing Syndrome Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cushing syndrome market vendors that include Bristol Myers Squibb Co., Corcept Therapeutics Inc., HRA Pharma Rare Diseases, Novartis AG, Pfizer Inc., Recordati S.p.A, Sparrow Pharmaceuticals, and Xeris Biopharma Holdings Inc.. Also, the cushing syndrome market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Customer Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Cushing Syndrome Market 2019 - 2023; Historic Market Size - Data Table on Global Cushing Syndrome Market 2019 - 2023 ($ million); 5.2 Distribution Channel segment analysis 2019 - 2023; Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); 5.3 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ million); 5.4 Customer Type segment analysis 2019 - 2023; Historic Market Size - Customer Type Segment 2019 - 2023 ($ million); 5.5 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.6 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI on Global Cushing Syndrome Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Distribution Channel: 8.1 Market segments; Chart on Distribution Channel - Market share 2024-2029 (%); Data Table on Distribution Channel - Market share 2024-2029 (%); 8.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 8.3 Hospital pharmacy - Market size and forecast 2024-2029; Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million); Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million); Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%); Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%); 8.4 Retail pharmacy - Market size and forecast 2024-2029; Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million); Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million); Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%); Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%); 8.5 Online pharmacy - Market size and forecast 2024-2029; Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million); Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million); Chart on Online pharmacy - Year-over-year growth 2024-2029 (%); Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%); 8.6 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Type: 9.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 9.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 9.3 Glucocorticoid receptor antagonists - Market size and forecast 2024-2029; Chart on Glucocorticoid receptor antagonists - Market size and forecast 2024-2029 ($ million); Data Table on Glucocorticoid receptor antagonists - Market size and forecast 2024-2029 ($ million); Chart on Glucocorticoid receptor antagonists - Year-over-year growth 2024-2029 (%); Data Table on Glucocorticoid receptor antagonists - Year-over-year growth 2024-2029 (%); 9.4 Pituitary directed drugs - Market size and forecast 2024-2029; Chart on Pituitary directed drugs - Market size and forecast 2024-2029 ($ million); Data Table on Pituitary directed drugs - Market size and forecast 2024-2029 ($ million); Chart on Pituitary directed drugs - Year-over-year growth 2024-2029 (%); Data Table on Pituitary directed drugs - Year-over-year growth 2024-2029 (%); 9.5 Steroidogenesis inhibitors - Market size and forecast 2024-2029; Chart on Steroidogenesis inhibitors - Market size and forecast 2024-2029 ($ million); Data Table on Steroidogenesis inhibitors - Market size and forecast 2024-2029 ($ million); Chart on Steroidogenesis inhibitors - Year-over-year growth 2024-2029 (%); Data Table on Steroidogenesis inhibitors - Year-over-year growth 2024-2029 (%); 9.6 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by Customer Type: 10.1 Market segments; Chart on Customer Type - Market share 2024-2029 (%); Data Table on Customer Type - Market share 2024-2029 (%); 10.2 Comparison by Customer Type; Chart on Comparison by Customer Type; Data Table on Comparison by Customer Type; 10.3 Adults - Market size and forecast 2024-2029; Chart on Adults - Market size and forecast 2024-2029 ($ million); Data Table on Adults - Market size and forecast 2024-2029 ($ million); Chart on Adults - Year-over-year growth 2024-2029 (%); Data Table on Adults - Year-over-year growth 2024-2029 (%); 10.4 Pediatrics - Market size and forecast 2024-2029; Chart on Pediatrics - Market size and forecast 2024-2029 ($ million); Data Table on Pediatrics - Market size and forecast 2024-2029 ($ million); Chart on Pediatrics - Year-over-year growth 2024-2029 (%); Data Table on Pediatrics - Year-over-year growth 2024-2029 (%); 10.5 Market opportunity by Customer Type; Market opportunity by Customer Type ($ million); Data Table on Market opportunity by Customer Type ($ million)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape: 12.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 12.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 12.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 12.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 12.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 12.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 12.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 12.8 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 12.9 Mexico - Market size and forecast 2024-2029; Chart on Mexico - Market size and forecast 2024-2029 ($ million); Data Table on Mexico - Market size and forecast 2024-2029 ($ million); Chart on Mexico - Year-over-year growth 2024-2029 (%); Data Table on Mexico - Year-over-year growth 2024-2029 (%); 12.10 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 12.11 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 12.12 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 12.13 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 12.14 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ million); Data Table on Italy - Market size and forecast 2024-2029 ($ million); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 12.15 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 12.16 The Netherlands - Market size and forecast 2024-2029; Chart on The Netherlands - Market size and forecast 2024-2029 ($ million); Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million); Chart on The Netherlands - Year-over-year growth 2024-2029 (%); Data Table on The Netherlands - Year-over-year growth 2024-2029 (%); 12.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints: 13.1 Market drivers; 13.2 Market challenges; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 13.4 Market opportunities/restraints
14 Competitive Landscape: 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business
15 Competitive Analysis: 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; SWOT; 15.5 Corcept Therapeutics Inc.; Corcept Therapeutics Inc. - Overview; Corcept Therapeutics Inc. - Product / Service; Corcept Therapeutics Inc. - Key offerings; SWOT; 15.6 HRA Pharma Rare Diseases; HRA Pharma Rare Diseases - Overview; HRA Pharma Rare Diseases - Product / Service; HRA Pharma Rare Diseases - Key offerings; SWOT; 15.7 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 15.8 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 15.9 Recordati S.p.A; Recordati S.p.A - Overview; Recordati S.p.A - Business segments; Recordati S.p.A - Key offerings; Recordati S.p.A - Segment focus; SWOT; 15.10 Sparrow Pharmaceuticals; Sparrow Pharmaceuticals - Overview; Sparrow Pharmaceuticals - Product / Service; Sparrow Pharmaceuticals - Key offerings; SWOT; 15.11 Xeris Biopharma Holdings Inc.; Xeris Biopharma Holdings Inc. - Overview; Xeris Biopharma Holdings Inc. - Product / Service; Xeris Biopharma Holdings Inc. - Key offerings; SWOT
16 Appendix: 16.1 Scope of the report; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis; 360 degree market analysis; 16.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Market Segmentation by Customer Type; Exhibits8: Executive Summary - Chart on Incremental Growth; Exhibits9: Executive Summary - Data Table on Incremental Growth; Exhibits10: Executive Summary - Chart on Company Market Positioning; Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits12: Overview on criticality of inputs and factors of differentiation; Exhibits13: Overview on factors of disruption; Exhibits14: Impact of drivers and challenges in 2024 and 2029; Exhibits15: Parent Market; Exhibits16: Data Table on - Parent Market; Exhibits17: Market characteristics analysis; Exhibits18: Value chain analysis; Exhibits19: Offerings of companies included in the market definition; Exhibits20: Market segments; Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Historic Market Size - Data Table on Global Cushing Syndrome Market 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Type Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - Customer Type Segment 2019 - 2023 ($ million); Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits31: Five forces analysis - Comparison between 2024 and 2029; Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits37: Chart on Market condition - Five forces 2024 and 2029; Exhibits38: Chart on Distribution Channel - Market share 2024-2029 (%); Exhibits39: Data Table on Distribution Channel - Market share 2024-2029 (%); Exhibits40: Chart on Comparison by Distribution Channel; Exhibits41: Data Table on Comparison by Distribution Channel; Exhibits42: Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million); Exhibits43: Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million); Exhibits44: Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%); Exhibits45: Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%); Exhibits46: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million); Exhibits47: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million); Exhibits48: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%); Exhibits49: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%); Exhibits50: Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million); Exhibits51: Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million); Exhibits52: Chart on Online pharmacy - Year-over-year growth 2024-2029 (%); Exhibits53: Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%); Exhibits54: Market opportunity by Distribution Channel ($ million); Exhibits55: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits56: Chart on Type - Market share 2024-2029 (%); Exhibits57: Data Table on Type - Market share 2024-2029 (%); Exhibits58: Chart on Comparison by Type; Exhibits59: Data Table on Comparison by Type; Exhibits60: Chart on Glucocorticoid receptor antagonists - Market size and forecast 2024-2029 ($ million); Exhibits61: Data Table on Glucocorticoid receptor antagonists - Market size and forecast 2024-2029 ($ million); Exhibits62: Chart on Glucocorticoid receptor antagonists - Year-over-year growth 2024-2029 (%); Exhibits63: Data Table on Glucocorticoid receptor antagonists - Year-over-year growth 2024-2029 (%); Exhibits64: Chart on Pituitary directed drugs - Market size and forecast 2024-2029 ($ million); Exhibits65: Data Table on Pituitary directed drugs - Market size and forecast 2024-2029 ($ million); Exhibits66: Chart on Pituitary directed drugs - Year-over-year growth 2024-2029 (%); Exhibits67: Data Table on Pituitary directed drugs - Year-over-year growth 2024-2029 (%); Exhibits68: Chart on Steroidogenesis inhibitors - Market size and forecast 2024-2029 ($ million); Exhibits69: Data Table on Steroidogenesis inhibitors - Market size and forecast 2024-2029 ($ million); Exhibits70: Chart on Steroidogenesis inhibitors - Year-over-year growth 2024-2029 (%); Exhibits71: Data Table on Steroidogenesis inhibitors - Year-over-year growth 2024-2029 (%); Exhibits72: Market opportunity by Type ($ million); Exhibits73: Data Table on Market opportunity by Type ($ million); Exhibits74: Chart on Customer Type - Market share 2024-2029 (%); Exhibits75: Data Table on Customer Type - Market share 2024-2029 (%); Exhibits76: Chart on Comparison by Customer Type; Exhibits77: Data Table on Comparison by Customer Type; Exhibits78: Chart on Adults - Market size and forecast 2024-2029 ($ million); Exhibits79: Data Table on Adults - Market size and forecast 2024-2029 ($ million); Exhibits80: Chart on Adults - Year-over-year growth 2024-2029 (%); Exhibits81: Data Table on Adults - Year-over-year growth 2024-2029 (%); Exhibits82: Chart on Pediatrics - Market size and forecast 2024-2029 ($ million); Exhibits83: Data Table on Pediatrics - Market size and forecast 2024-2029 ($ million); Exhibits84: Chart on Pediatrics - Year-over-year growth 2024-2029 (%); Exhibits85: Data Table on Pediatrics - Year-over-year growth 2024-2029 (%); Exhibits86: Market opportunity by Customer Type ($ million); Exhibits87: Data Table on Market opportunity by Customer Type ($ million); Exhibits88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits89: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits90: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits91: Chart on Geographic comparison; Exhibits92: Data Table on Geographic comparison; Exhibits93: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits94: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits95: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits96: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits97: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits98: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits99: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits102: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits103: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on Canada - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on Canada - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Mexico - Market size and forecast 2024-2029 ($ million); Exhibits118: Data Table on Mexico - Market size and forecast 2024-2029 ($ million); Exhibits119: Chart on Mexico - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Mexico - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits126: Data Table on UK - Market size and forecast 2024-2029 ($ million); Exhibits127: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on China - Market size and forecast 2024-2029 ($ million); Exhibits130: Data Table on China - Market size and forecast 2024-2029 ($ million); Exhibits131: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on France - Market size and forecast 2024-2029 ($ million); Exhibits134: Data Table on France - Market size and forecast 2024-2029 ($ million); Exhibits135: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on Italy - Market size and forecast 2024-2029 ($ million); Exhibits138: Data Table on Italy - Market size and forecast 2024-2029 ($ million); Exhibits139: Chart on Italy - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on Italy - Year-over-year growth 2024-2029 (%); Exhibits141: Chart on Japan - Market size and forecast 2024-2029 ($ million); Exhibits142: Data Table on Japan - Market size and forecast 2024-2029 ($ million); Exhibits143: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits144: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits145: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million); Exhibits146: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million); Exhibits147: Chart on The Netherlands - Year-over-year growth 2024-2029 (%); Exhibits148: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%); Exhibits149: Market opportunity By Geographical Landscape ($ million); Exhibits150: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits151: Impact of drivers and challenges in 2024 and 2029; Exhibits152: Overview on criticality of inputs and factors of differentiation; Exhibits153: Overview on factors of disruption; Exhibits154: Impact of key risks on business; Exhibits155: Companies covered; Exhibits156: Company ranking index; Exhibits157: Matrix on companies position and classification; Exhibits158: Bristol Myers Squibb Co. - Overview; Exhibits159: Bristol Myers Squibb Co. - Product / Service; Exhibits160: Bristol Myers Squibb Co. - Key news; Exhibits161: Bristol Myers Squibb Co. - Key offerings; Exhibits162: SWOT; Exhibits163: Corcept Therapeutics Inc. - Overview; Exhibits164: Corcept Therapeutics Inc. - Product / Service; Exhibits165: Corcept Therapeutics Inc. - Key offerings; Exhibits166: SWOT; Exhibits167: HRA Pharma Rare Diseases - Overview; Exhibits168: HRA Pharma Rare Diseases - Product / Service; Exhibits169: HRA Pharma Rare Diseases - Key offerings; Exhibits170: SWOT; Exhibits171: Novartis AG - Overview; Exhibits172: Novartis AG - Business segments; Exhibits173: Novartis AG - Key news; Exhibits174: Novartis AG - Key offerings; Exhibits175: Novartis AG - Segment focus; Exhibits176: SWOT; Exhibits177: Pfizer Inc. - Overview; Exhibits178: Pfizer Inc. - Product / Service; Exhibits179: Pfizer Inc. - Key news; Exhibits180: Pfizer Inc. - Key offerings; Exhibits181: SWOT; Exhibits182: Recordati S.p.A - Overview; Exhibits183: Recordati S.p.A - Business segments; Exhibits184: Recordati S.p.A - Key offerings; Exhibits185: Recordati S.p.A - Segment focus; Exhibits186: SWOT; Exhibits187: Sparrow Pharmaceuticals - Overview; Exhibits188: Sparrow Pharmaceuticals - Product / Service; Exhibits189: Sparrow Pharmaceuticals - Key offerings; Exhibits190: SWOT; Exhibits191: Xeris Biopharma Holdings Inc. - Overview; Exhibits192: Xeris Biopharma Holdings Inc. - Product / Service; Exhibits193: Xeris Biopharma Holdings Inc. - Key offerings; Exhibits194: SWOT; Exhibits195: Inclusions checklist; Exhibits196: Exclusions checklist; Exhibits197: Currency conversion rates for US$; Exhibits198: Research methodology; Exhibits199: Information sources; Exhibits200: Data validation; Exhibits201: Validation techniques employed for market sizing; Exhibits202: Data synthesis; Exhibits203: 360 degree market analysis; Exhibits204: List of abbreviations

Pricing

Currency Rates

Single User Online Download $2,500
Global Site License Online Download $4,000

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now